Download PDF
Nuklearmedizin 1976; 15(03): 131-134
DOI: 10.1055/s-0038-1624946
Originalarbeiten — Original Articles
Schattauer GmbH

Significance of Renal Visualization during Bone Scanning in Paget’s Disease

Die Bedeutuug der Nierendarstellung in Knochenszintigrammen bei Patienten mit M. Paget
P. F. Winter
1   From the Division of Nuclear Medicine, Columbia University, College of Physicians and Surgeons, New York
,
Ph. M. Johnson
1   From the Division of Nuclear Medicine, Columbia University, College of Physicians and Surgeons, New York
› Author Affiliations
Further Information

Publication History

Received:21 January 1976

Publication Date:
11 January 2018 (online)

Also available at
    Permissions and Reprints

Summary

In 17 of 26 patients with extensive, symptomatic Paget’s disease poor renal visualization was noted on bone scanning with 99mTc-diphosphonate. Renal function was normal in all patients. The intensity of the renal image proved to be inversely related to the extent and metabolic activity of the Pagetic process. This finding supports the hypothesis that in Paget’s disease the balance between skeletal and renal extraction of circulating tracer may be displaced in favor of the former.

Siebzehn von 26 Patienten mit fortgeschrittenem, symptomatischem Morbus Paget hatten eine verminderte Nierenradioaktivität im Knochenszintigramm mit 99mTc-Diphosphonat. Die Nierenfunktion aller Patienten war normal. Die Intensität der Nierendarstellung verhielt sich umgekehrt zum Ausmaß und zur metabolischen Aktivität des Morbus Paget. Diese Beobachtung unterstützt die Hypothese, daß bei Morbus Paget das Verhältnis zwischen Knochen- und Nierenextraktion des zirkulierenden Radiopharmakons zugunsten der Knochenaufnahme verschoben ist.

The Paget’s disease treatment program at this institution has been supported by the NIH grants AM-09579 and RR-00645.


 

  • References

  • 1 Subramanian G, McAfee J. G, Bell E. G. et al Technetium 99m-labeled polyphosphate as a skeletal imaging agent. Radiology 1972; 102: 701-704.
    CrossrefPubMedGoogle Scholar
  • 2 Park C. H, Glassman L. M, Tompson N. L. et al Reliability of renal imaging obtained incidentally in 99mTc-polyphosphate bone scanning. J. Nucl. Med 1973; 14: 534-536.
    PubMedGoogle Scholar
  • 3 Krishnamurthy G. T, Tubis M, Endow J. S. et al Clinical comparison of kinetics of technetium-99m labeled polyphosphate and diphosphonate. J. Nucl. Med 1974; 15: 848-855.
    PubMedGoogle Scholar
  • 4 Sy W. M, Patel D, Faunce H. Significance of absent or faint kidney sign on bone scan. J. Nucl. Med 1975; 16: 454-456.
    PubMedGoogle Scholar
  • 5 Roy A. V. Rapid method for determining alkaline phosphatase activity in serum with thymolphthalein monophosphate. Clin. Chem 1970; 16: 431-436.
    PubMedGoogle Scholar
  • 6 Kivirikko K. I, Laitinen O, Prockop D. J. Modifications of a specific assay for hydroxyproline in urine. Anal. Biochem 1967; 19: 249-455.
    CrossrefPubMedGoogle Scholar
  • 7 Howarth S. Cardiac output in osteitis deformans. Clin. SeI 1953; 12: 271-275.
    Google Scholar
  • 8 Miller S. W, CastronovoH F. P, Pendergrass P. et al Technetium-99m-labeled diphosphonate bone scanning in Paget’s disease. Amer. J. Roentgenol 1974; 121: 177-183.
    CrossrefPubMedGoogle Scholar
  • 9 Winter P. F, Johnson P. M. Unpublished data.
    Google Scholar
  • 10 Guncaga J, Lauffenburger T. H, Leutner C. et al. Diphosphonate treatment of Paget’s disease of bone. Horm. Metab. Res 1974; 6: 62-69.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Khrairi M. R. A, Wellman H. N, Robb J. A. et al Paget’s disease of bone (osteitis deformans): symptomatic lesions and bone scan. Ann. Intern. Med 1973; 79: 348-351.
    CrossrefPubMedGoogle Scholar
  • 12 DeDeuxchaisnes C. N, Krane S. M. Paget’s disease of bone, clinical and metabolic observations. Medicine (Baltimore) 1964; 43: 233-266.
    CrossrefPubMedGoogle Scholar
  • 13 Woodhouse N. J. Y. Paget’s disease of bone. Clin. Endocr. Metab 1972; 1: 125-141.
    CrossrefGoogle Scholar
  • 14 Serafini A, Altman R, Sankey T. et al Paget’s disease: a method of evaluation of response to therapy using the Anger scintillation camera on-line to a computer (Abstract). J. Nucl. Med 1973; 14: 449.
    Google Scholar